<DOC>
	<DOC>NCT00887601</DOC>
	<brief_summary>This study will evaluate functional magnetic resonance imaging (fMRI) and methods for measuring drug induced changes in cerebral blood flow as biomarkers for attention-improving drugs.</brief_summary>
	<brief_title>BOLD Functional Magnetic Resonance Imaging (fMRI) and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs (3134-006)</brief_title>
	<detailed_description />
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<mesh_term>Nootropic Agents</mesh_term>
	<criteria>Subject is a nonsmoker Subject is in generally good health Subject has normal (or corrected to normal) vision and hearing Subject is righthanded Subject has a history of any illness that would make participation unsafe or would make the study results difficult to interpret Subject has a history of stroke, seizures, or major neurological disorders Subject has a history of cancer Subject has permanent cosmetic or metallic implants that would interfere with measurements Subject has a history of sleep apnea Subject has a history of head injury/trauma</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>